Treatment of refractory Hodgkin's disease with teniposide, cisplatin, hexamethylmelamine, and prednisolone: cancer and leukemia group B trial 8171. Academic Article uri icon

Overview

publication date

  • June 1, 1985

Research

keywords

  • Antineoplastic Combined Chemotherapy Protocols
  • Hodgkin Disease

Identity

Scopus Document Identifier

  • 0021869124

PubMed ID

  • 3926312

Additional Document Info

volume

  • 69

issue

  • 6